<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A double-blind controlled trial of oral <z:chebi fb="4" ids="35176">zinc sulphate</z:chebi> as adjuvant treatment in idiopathic <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> or <z:mp ids='MP_0003305'>proctitis</z:mp> in relapse is reported </plain></SENT>
<SENT sid="1" pm="."><plain>Fifty-one patients were treated, and the clinical and sigmoidoscopic improvement in the zinc treated patients was similar to that in patients receiving placebo </plain></SENT>
<SENT sid="2" pm="."><plain>No difference was found between plasma zinc levels in a further 46 patients with idiopathic <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> or <z:mp ids='MP_0003305'>proctitis</z:mp> and those obtained in a group of healthy controls </plain></SENT>
</text></document>